Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
PARA Paramount Global
TFINP Triumph Financial Inc
HWKN Hawkins Inc
COUP Coupa Software Inc
ACAZF Acadian Timber Corp
BSX Boston Scientific Corp
ACDVF Air Canada
DCFCW Tritium DCFC Equity Warrant Exp 13th Jan 2027 *W EXP 01/13/2027
CBWTF Auxly Cannabis Group Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Premarket

Last Trade
Delayed
$147.08
-0.32 (-0.22%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$147.40
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
2,498

10-day average volume:
6,655,784
2,498

Upcoming Events

ABBV's fiscal year ends in December
There are no upcoming events for ABBV

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
October 28, 2022Q3 2022 Earnings Release$3.66$3.51 to $3.70$2.83
July 29, 2022Q2 2022 Earnings Release$3.37$3.21 to $3.49$3.03
April 29, 2022Q1 2022 Earnings Release$3.16$3.10 to $3.20$2.89
February 2, 2022Q4 2021 Earnings Release$3.08$3.21 to $3.39--

Past Dividends

Ex-dividend dateAmountRecord datePay date
January 12, 2023$1.48January 13, 2023February 15, 2023
October 13, 2022$1.41October 14, 2022November 15, 2022
July 14, 2022$1.41July 15, 2022August 15, 2022
April 13, 2022$1.41April 15, 2022May 16, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.